Abstract:BACKGROUND<br />Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising from the biliary tree. Radical surgery is the only treatment offering a chance of long-term survival. However, limited by the tumor's anatomic location and peri-vascular invasion, most patients lose the chance for curative treatment. Therefore, more methods to increase the resectability of tumors as well as to improve outcomes are needed.CASE SUMMARY<br />A 68-year-old female patient had a hepatic hilar mass without obvious symptoms. Laboratory results showed hepatitis B positivity. Magnetic resonance imaging indicated that the mass (maximum diameter: 41 mm) invaded the left and right branches of the main portal vein, as well as the middle, left and right hepatic veins; enlarged lymph nodes were also detected in the hilum. The patient was diagnosed with pCCA, and the clinical stage was determined to be T4N1M0 (stage IIIC). Considering the tumor's anatomic location and vascular invasion, systematic conversion therapy followed by ex vivo liver resection and autotransplantation (ELRA) was determined as personalized treatment for this patient. Our original systemic sequential therapeutic strategy (lenvatinib and tislelizumab in combination with gemcitabine and cisplatin) was successfully adopted as conversion therapy because she achieved partial response after three cycles of treatment, without severe toxicity. ELRA, anastomotic reconstruction of the middle hepatic vein, right hepatic vein, root of portal vein, inferior vena cava and right hepatic artery, and lymph node dissection were performed at one month after systemic therapy. Pathological and immunohistochemical examination confirmed the diagnosis of pCCA with lymph node metastasis. Although the middle hepatic vein was partially obstructed four months later, hepatic vein stent implantation successfully addressed this problem. The patient has survived for 22 mo after the diagnosis, with no evidence of recurrence or metastasis.CONCLUSION<br />An effective therapeutic strategy for conversion therapy greatly increases the feasibility and efficiency of ELRA.

Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes.

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Recent outcomes of liver transplantation for Budd Chiari Syndrome – a study of the European Liver Transplant Registry (ELTR) and affiliated centers

Multiple venous thrombosis with recurrence of Budd‐Chiari syndrome after liver transplantation for paroxysmal nocturnal hematuria

Liver transplantation for acute Budd‐Chiari syndrome complicated by portal and inferior vena cava thrombosis

Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients

Analysis of Surgical Treatment Results in 120 Cases of Budd-Chiari Syndrome

Living donor liver transplantation on pediatric patient with Budd-Chiari syndrome: Case report and literature review

Budd-Chiari syndrome complicating hepatic sarcoidosis: definitive treatment by liver transplantation: a case report

Pediatric living donor liver transplant for Budd-Chiari syndrome using a cryopreserved pulmonary vein graft for retro-hepatic vena cava reconstruction: A case report

[Current status and future directions in chemotherapy for biliary tract carcinoma].

A self calibrating 12b 12µs CMOS ADC

Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome

Interventional and Surgical Treatment of Budd-Chiari Syndrome: A Report of 39 Cases

Liver transplantation for organ failure following multiple locoregional treatments for breast cancer metastasis

TIPS with a Twist - The Real Life Management of a Case of Budd-Chiari-related Acute Liver and Subsequent Multiple Organ Failure

Long Term Outcomes of Budd-Chiari Syndrome Patients Undergoing Radical Resection with Full Exposure of the Inferior Vena Cava of the Hepatic Segmen

Latent Informative Links Detection

Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients with Cirrhosis

Long-term outcome of combined radiologic and surgical strategy for the management of biliary complications after pediatric liver transplantation

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis